Healthcare - Biotechnology - NASDAQ - IL
$ 2.93
-5.48 %
$ 4.42 M
Market Cap
-0.27
P/E
CASH FLOW STATEMENT
-6.14 M
OPERATING CASH FLOW
800 K
INVESTING CASH FLOW
6.18 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Galmed Pharmaceuticals Ltd.
| Net Income | -6.91 M |
| Depreciation & Amortization | 31 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 892 K |
| Change in Working Capital | 132 K |
| Others | 188 K |
| Free Cash Flow | -6.14 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (6.9) | (17.9) | (32.5) | (28.8) | (20.5) | (9.9) | (12.3) | (17.0) | (10.6) | (9.1) | (17.5) | (3.1) |
| Depreciation & Amortization | 31 K | 35 K | 42 K | 39 K | 35 K | 0.4 | 0.2 | 0.2 | 50 K | 9 K | 4 K | 5 K |
| Deferred Income Tax | 0 | 0 | 84 K | (0.4) | (0.1) | 12 K | 0.2 | (1.4) | (0.9) | (0.6) | 0 | (0.2) |
| Stock Based Compensation | 0.9 | 1.3 | 1.9 | 2.1 | 2.2 | 1.8 | 1.4 | 1.6 | 1.0 | 0.6 | 10.9 | 0.2 |
| Other Operating Activities | (0.3) | 0.5 | 13 K | (0.3) | 63 K | (0.1) | (0.2) | 1.7 | 1.1 | 0.6 | 2.9 | 0.2 |
| Change in Working Capital | 0.1 | (2.5) | (2.5) | 1.1 | 3.4 | (1.2) | (1.4) | 2.8 | 1.0 | (0.7) | 1.2 | (0.1) |
| Cash From Operations | (6.1) | (18.5) | (32.9) | (26.3) | (14.9) | (9.0) | (12.1) | (12.1) | (8.5) | (9.2) | (2.5) | (3.1) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 0 | 4 K | 11 K | 44 K | 12 K | 90 K | 21 K | 17 K | (0.2) | (0.8) | 13 K | 32 K |
| Other Items | 0.8 | 17.6 | 11.5 | 16.6 | 6.7 | (59.9) | 6.5 | 6.4 | (10.9) | (8.2) | 16 K | 0 |
| Cash From Investing Activities | 0.8 | 17.6 | 11.5 | 16.5 | 6.7 | (60.0) | 6.4 | 6.3 | (11.1) | (9.0) | 3 K | 32 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.8 | 20 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 61 K | 0.1 | 1.0 | 0.5 | 0.3 | 0 | 0 | 0 | 3.7 |
| Cash From Financing Activities | 6.2 | 70 K | 17.4 | 0.8 | 0.1 | 80.2 | 15.5 | 4.7 | 0 | 41.9 | 1.9 | 3.7 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 0.8 | (0.9) | (4.1) | (9.0) | (8.1) | 11.1 | 9.9 | (1.1) | (19.6) | 23.6 | (0.6) | 0.6 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (6.1) | (18.5) | (32.9) | (26.3) | (14.9) | (9.1) | (12.1) | (12.1) | (8.6) | (10.0) | (2.5) | (3.1) |